Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Dynamic changes of multi-notoginseng stem-leaf ginsenosides in reaction with ginsenosidase type-I

  • Xiao, Yongkun (Department of Oriental Medicinal Biotechnology, College of Life Science, Kyung Hee University) ;
  • Liu, Chunying (College of Biotechnology, Dalian Polytechnic University) ;
  • Im, Wan-Teak (Department of Biotechnology, Hankyoung National University) ;
  • Chen, Shuang (College of Biotechnology, Dalian Polytechnic University) ;
  • Zuo, Kangze (College of Biotechnology, Dalian Polytechnic University) ;
  • Yu, Hongshan (College of Biotechnology, Dalian Polytechnic University) ;
  • Song, Jianguo (College of Biotechnology, Dalian Polytechnic University) ;
  • Xu, Longquan (College of Biotechnology, Dalian Polytechnic University) ;
  • Yi, Tea-Hoo (Department of Oriental Medicinal Biotechnology, College of Life Science, Kyung Hee University) ;
  • Jin, Fengxie (College of Biotechnology, Dalian Polytechnic University)
  • Received : 2017.02.22
  • Accepted : 2017.10.11
  • Published : 2019.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Notoginseng stem-leaf (NGL) ginsenosides have not been well used. To improve their utilization, the biotransformation of NGL ginsenosides was studied using ginsenosidase type-I from Aspergillus niger g.848. Methods: NGL ginsenosides were reacted with a crude enzyme in the RAT-5D bioreactor, and the dynamic changes of multi-ginsenosides of NGL were recognized by HPLC. The reaction products were separated using a silica gel column and identified by HPLC and NMR. Results: All the NGL ginsenosides are protopanaxadiol-type ginsenosides; the main ginsenoside contents are 27.1% Rb3, 15.7% C-Mx1, 13.8% Rc, 11.1% Fc, 7.10% Fa, 6.44% C-Mc, 5.08% Rb2, and 4.31% Rb1. In the reaction of NGL ginsenosides with crude enzyme, the main reaction of Rb3 and C-Mx1 occurred through Rb3${\rightarrow}$C-Mx1${\rightarrow}$C-Mx; when reacted for 1 h, Rb3 decreased from 27.1% to 9.82 %, C-Mx1 increased from 15.5% to 32.3%, C-Mx was produced to 6.46%, finally into C-Mx and a small amount of C-K. When reacted for 1.5 h, all the Rb1, Rd, and Gyp17 were completely reacted, and the reaction intermediate F2 was produced to 8.25%, finally into C-K. The main reaction of Rc (13.8%) occurred through Rc${\rightarrow}$C-Mc1${\rightarrow}$C-Mc${\rightarrow}$C-K. The enzyme barely hydrolyzed the terminal xyloside on 3-O- or 20-O-sugar-moiety of the substrate; therefore, 9.43 g C-Mx, 6.85 g C-K, 4.50 g R7, and 4.71 g Fc (hardly separating from the substrate) were obtained from 50 g NGL ginsenosides by the crude enzyme reaction. Conclusion: Four monomer ginsenosides were successfully produced and separated from NGL ginsenosides by the enzyme reaction.

Keywords

References

  1. Jin FX. Biotransformation of natural products. Beijing: Chemical Industry Press; 2009. p. 74-113 [in Chinese].
  2. Christensen LP. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 2009;55:1-99. https://doi.org/10.1016/S1043-4526(08)00401-4
  3. Liu CY, Song JG, Li PF, Yu HS, Jin FX. Ginsenoside contents in three different ginseng. J Dalian Polytech Univ 2011;30:79-82.
  4. Li PF, Liu CY, Guo JY, He D, Yu HS, Jin FX. Comparison of ginsenosides on different ginseng stem. J Anhui Agric Sci 2010;34:13077-9.
  5. Zhang JT. Ginseng is the King of Herbs-Ginseng chemistry, physiology activity and pharmacokinetics. Beijing: Chemical Industry Press; 2008. p. 34-44 [in Chinese].
  6. Huang F, Xiang FJ, Wu JX. Research progress on the extraction and separation of ginsenosides from Notoginseng stem life. J Chinese Med Mater 2009;32: 999-1005.
  7. Kobashi K. Glycosides are natural prodrugs-evidence using germ-free and gnotobiotic rats associated with a human intestinal bacterium. J Trad Med 1998;15:1-13.
  8. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after administration. Drug Metab Dispos 2003;31: 1065-71. https://doi.org/10.1124/dmd.31.8.1065
  9. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 2004;95:153-7. https://doi.org/10.1254/jphs.FMJ04001X4
  10. Popovich DG, Kitts DD. Structure-function relationship exists forginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch Biochem Biophys 2002;406:1-8. https://doi.org/10.1016/S0003-9861(02)00398-3
  11. Cui CH, Kim SC, Im WT. Characterization of the ginsenoside transforming recombinant b-glucosidase from Actinosynnema mirum and bioconversion of major ginsenosides into minor ginsenosides. Appl Microbiol Biotech 2013;97: 649-59. https://doi.org/10.1007/s00253-012-4324-5
  12. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 1996;62:453-7. https://doi.org/10.1055/s-2006-957938
  13. Park CS, Yoo MH, Noh KH, Oh DK. Biotransformation of ginsenosides by hydrolyzing sugar moieties of ginsenosides using microbial glycosidases. Appl Microbiol Biotechnol 2010;87:9-19. https://doi.org/10.1007/s00253-010-2567-6
  14. Leung KW, Wong AS. Pharmacology of ginsenosides: a literature review. Chin Med 2010;5:20-2. https://doi.org/10.1186/1749-8546-5-20
  15. Choi S, Kim TW, Singh SV. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases. Pharm Res 2009;26: 2280-8. https://doi.org/10.1007/s11095-009-9944-9
  16. Choi SH, Shin TJ, Hwang SH, Lee BH, Kang J, Kim HJ. Differential effects of ginsenoside metabolites on HERG k channel currents. J Ginseng Res 2011;35:191-9. https://doi.org/10.5142/jgr.2011.35.2.191
  17. Kim YJ, Yamabe N, Choi P, Lee JW, Ham J, Kang KS. Efficient thermal deglycosylation of ginsenoside Rd and its contribution to the improved anticancer activity of ginseng. J Agric Food Chem 2013;61:9185-91. https://doi.org/10.1021/jf402774d
  18. Kim SJ, Kang BY, Cho SY, Sung DS, Chang HK, Yeom MH, Kim DH, Sim YC, Lee YS. Compound K induces expression of hyaluronan synthase 2 gene in transformed human keratinocytes and increases hyaluronan in hairless mouse skin. Biochem Biophys Res Commun 2004;316:348-55. https://doi.org/10.1016/j.bbrc.2004.02.046
  19. Kim M, Ahn BY, Lee JS, Chung SS, Lim S, Park SG, Jung HS, Lee HK, Park KS. The ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubes. Biochem Biophys Res Commun 2009;389:70-3. https://doi.org/10.1016/j.bbrc.2009.08.088
  20. Sun S, Wang CZ, Tong RL, Xiao L, Fishbein AWQ, He TC, Du W, Yuan CS. Effects of steaming the root of Panax notoginseng on chemical composition and anticancer activities. Food Chem 2010;118:307-14. https://doi.org/10.1016/j.foodchem.2009.04.122
  21. Sala F, Mulet J, Choi S, Jung SY, Nah SY, Rhim H, Valor LM, Criado M, Sala S. Effects of ginsenoside Rg2 on human neuronal nicotinic acetylcholine receptors. J Pharmacol Exp Ther 2002;301:1052-9. https://doi.org/10.1124/jpet.301.3.1052
  22. Jin FX, Yu HS, Fu Yaoyao, An DS, Im WT, Lee ST, Jaime A. Teixeira da Silva: biotransformation of ginsenosides (ginseng saponins). Int J Biomed Pharm Sci 2012;6(Special Issue):33-44.
  23. Yu HS, Zhang CZ, Lu MC, Sun F, Fu YY, Jin FX. Purification and characterization of new special ginsenosidase hydrolyzing multi-glycisides of protopanaxadiol ginsenosides, ginsenosidase type I. Chem Pharm Bull 2007;55:231-5. https://doi.org/10.1248/cpb.55.231
  24. Liu CY, Jin YH, Yu HS, Sun CK, Gao P, Xiao YK, Zhang TY, Xu LQ, Im WT, Jin FX. Biotransformation pathway and kinetics of ginsenosidase type I hydrolyzing 3-O- and 20-O-multi- glucosides of PPD type ginsenosides. Process Biochem 2014;49:813-20. https://doi.org/10.1016/j.procbio.2014.02.011
  25. Liu CY, Zhou RX, Sun CK, Jin YH, Yu HS, Zhang TY, Xu LQ, Jin FX. Preparation of minor ginsenoside C-Mc, C-Y, F2 and C-K from American ginseng PPDginsenoside using special ginsenosidase type-I from Aspegillus niger g.848. J Ginseng Res 2015;39:221-9. https://doi.org/10.1016/j.jgr.2014.12.003
  26. Liu CY, Zou KZ, Yu HS, Sun CK, Zhang TY, Xu LQ, Jin YH, Im WT, Jin FX. Preparation of minor ginsenosides C-Mx and C-K from notoginseng leaf ginsenosides by a special ginsenosidase type-I. Process Biochem 2015;50:2158-67. https://doi.org/10.1016/j.procbio.2015.10.011
  27. Jin XF, Yu HS, Wang DM, Liu TQ, Liu CY, An DS, Im WT, Kim SG, Jin FX. Kinetics of a cloned special ginsenosidase hydrolyzing 3-O-glucoside of multiprotopanaxadiol-type ginsenosides, named ginsenosidase type III. J Microbiol Biotechnol 2012;22:343-51. https://doi.org/10.4014/jmb.1107.07066
  28. Wang DM, Yu HS, Song JG, Xu YF, Jin FX. Enzyme kinetics of ginsenosidase type IV hydrolyzing 6-O-multi-glycosides of protopanaxatriol type ginsenosides. Process Biochem 2012;47:133-8. https://doi.org/10.1016/j.procbio.2011.10.026
  29. Tanaka I, Kasai R. Saponins of ginseng and related plants. Progress in the chemistry of organic natural products, vol. 46. Berlin: Springer; 1984. p. 1-76.
  30. Duc NM, Kasai R, Ohtani K, Ito A, Nham NT, Yamasaki K, Tanaka O. Saponins from Vietnamese ginseng, Panax vietnamensis HA et Grushv. Collected in central Vietnam.II. Chem Pharm Bull 1994;42:115-22. https://doi.org/10.1248/cpb.42.115
  31. Yang TR, Kasai R, Zhou J, Tanaka O. Dammarane saponins of leaves and seeds of Panax Notoginseng. Phytochemistry 1983;22:1473-8. https://doi.org/10.1016/S0031-9422(00)84039-X

Cited by

  1. Photoprotective and Anti-Inflammatory Properties of Vina-Ginsenoside R7 Ameliorate Ultraviolet B-Induced Photodamage in Normal Human Dermal Fibroblasts vol.189, pp.3, 2019, https://doi.org/10.1007/s12010-019-03027-9